Please use this identifier to cite or link to this item:
|Title:||Anti-depressant-like activity of a novel serotonin type-3 (5-HT<sub>3</sub>) receptor antagonist in rodent models of depression|
Forced swim test
|Abstract:||<i style="">N</i>-Cyclohexyl-3-methoxyquinoxalin-2-carboxamide (QCM-13), a novel 5-HT<sub>3 </sub>antagonist identified from a series of compounds with higher pA<sub>2</sub> (7.6) and good log P (2.91) value was screened in rodent models of depression such as forced swim test (FST), tail suspension test (TST), interaction studies with standard anti-depressants and confirmatory studies such as reversal of parthenolide induced depression and reserpine induced hypothermia. In FST (2 and 4 mg/kg) and TST (2 and 4 mg/kg), QCM-13 significantly reduced the duration of immobility in mice without affecting the base line locomotion. QCM-13 (2 and 4 mg/kg) was also found to have significant interaction with standard anti-depressants (fluoxetine and bupropion in FST and TST respectively). Further, reversal of parthenolide induced depression in mice and reserpine induced hypothermia in rat models indicate the serotonergic influence of QCM-13 for anti-depressant potential.|
|ISSN:||0975-1009 (Online); 0019-5189 (Print)|
|Appears in Collections:||IJEB Vol.49(08) [August 2011]|
Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.